Repositori Institucional UIB
Publicación
Artículo científico (JournalArticle)
Enhancing Surgical Wound Monitoring: A Paired Cohort Study Evaluating a New AI-Based Application for Automatic Detection of Potential Infections
[eng] Background/Objectives: This study assessed the feasibility and security of remote surgicalwound monitoring using the RedScar© smartphone app, which employs automated diagnosis forearly visual detection of infections without direct healthcare personnel involvement. Additionally,patient satisfaction with telematic care was evaluated as a secondary aim. Surgical site infection (SSI)is the second leading cause of healthcare-associated infections (HAIs), leading to prolonged hospitalstays, heightened patient distress, and increased healthcare costs. Methods: The study employeda prospective paired-cohort and single-blinded design, with a sample size of 47 adult patientsundergoing abdominal surgery. RedScar© was used for remote telematic monitoring, evaluating thefeasibility and security of this approach. A satisfaction questionnaire assessed patient experience.The study protocol was registered at ClinicalTrials.gov under the identifier NCT05485233. Results:Out of 47 patients, 41 successfully completed both remote and in-person follow-ups. RedScar©demonstrated a sensitivity of 100% in detecting SSIs, with a specificity of 83.13%. The kappacoefficient of 0.8171 indicated substantial agreement between the application’s results and humanobservers. Patient satisfaction with telemonitoring was high: 97.6% believed telemonitoring reducescosts, 90.47% perceived it prevents work/school absenteeism, and 80.9% found telemonitoringcomfortable. Conclusions: This is the first study to evaluate an automatic smartphone application onreal patients for diagnosing postoperative wound infections. It establishes the safety and feasibilityof telematic follow-up using the RedScar© application for surgical wound assessment. The highsensitivity suggests its utility in identifying true cases of infection, highlighting its potential rolein clinical practice. Future studies are needed to address limitations and validate the efficacy ofRedScar© in diverse patient populations.